DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /GPCR & G Protein TargetsGPCR & G Protein Targets
  5. /LPL ReceptorLPL Receptor
  6. /Bms-986020Bms-986020
Chemical structure of CAS 1257213-50-5

Bms-986020

In Stock•Starting at $77 for 10 mg•Purity ≥ 99%
CAS No.1257213-50-5
MDL No.MFCD30489743
MFC29H26N2O5
MW482.50
InChI KeyGQBRZBHEPUQRPL-LJQANCHMSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
10 mg99%$77In Stock
25 mg99%$129In Stock
50 mg99%$217In Stock
100 mg99%$365In Stock
250 mg99%$619In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1257213-50-5
Product NameBms-986020

Biological Targets

LPAR1

Associated Conditions

scleroderma·idiopathic pulmonary fibrosis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis.

Chest • Vol. 154, Issue 5 • 2018
PMID: 30201408DOI: 10.1016/j.chest.2018.08.1058

Lysophospholipid receptors in drug discovery.

Experimental cell research • Vol. 333, Issue 2 • 2015
PMID: 25499971PMC: PMC4408218DOI: 10.1016/j.yexcr.2014.11.020

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact